BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31887227)

  • 1. Irradiance, Photofrin
    Oakley E; Bellnier D; Hutson A; Cooper H; Habitzruther M; Sexton S; Curtin L; Tworek L; Mallory M; Henderson B; Shafirstein G
    Photochem Photobiol; 2020 Mar; 96(2):397-404. PubMed ID: 31887227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irradiance controls photodynamic efficacy and tissue heating in experimental tumours: implication for interstitial PDT of locally advanced cancer.
    Shafirstein G; Bellnier DA; Oakley E; Hamilton S; Habitzruther M; Tworek L; Hutson A; Spernyak JA; Sexton S; Curtin L; Turowski SG; Arshad H; Henderson B
    Br J Cancer; 2018 Nov; 119(10):1191-1199. PubMed ID: 30353043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparison of Dose Metrics to Predict Local Tumor Control for Photofrin-mediated Photodynamic Therapy.
    Qiu H; Kim MM; Penjweini R; Finlay JC; Busch TM; Wang T; Guo W; Cengel KA; Simone CB; Glatstein E; Zhu TC
    Photochem Photobiol; 2017 Jul; 93(4):1115-1122. PubMed ID: 28083883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of fractionation and fluence rate in photodynamic therapy with Photofrin or mTHPC.
    van Geel IP; Oppelaar H; Marijnissen JP; Stewart FA
    Radiat Res; 1996 May; 145(5):602-9. PubMed ID: 8619026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy.
    Sitnik TM; Henderson BW
    Photochem Photobiol; 1998 Apr; 67(4):462-6. PubMed ID: 9559590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vivo Models for Studying Interstitial Photodynamic Therapy of Locally Advanced Cancer.
    Shafirstein G; Oakley E; Hamilton S; Habitzruther M; Chamberlain S; Sexton S; Curtin L; Bellnier DA
    Methods Mol Biol; 2022; 2451():151-162. PubMed ID: 35505016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photofrin
    Baran TM
    Lasers Surg Med; 2018 Jul; 50(5):476-482. PubMed ID: 29214668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy.
    Busch TM; Xing X; Yu G; Yodh A; Wileyto EP; Wang HW; Durduran T; Zhu TC; Wang KK
    Photochem Photobiol Sci; 2009 Dec; 8(12):1683-93. PubMed ID: 20024165
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Penjweini R; Kim MM; Ong YH; Zhu TC
    Phys Med Biol; 2020 Jan; 65(3):03LT01. PubMed ID: 31751964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of continuous low-irradiance photodynamic therapy in the treatment of chest wall progression of breast cancer.
    Morrison SA; Hill SL; Rogers GS; Graham RA
    J Surg Res; 2014 Dec; 192(2):235-41. PubMed ID: 25043529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy using intra-articular Photofrin for murine MRSA arthritis: biphasic light dose response for neutrophil-mediated antibacterial effect.
    Tanaka M; Kinoshita M; Yoshihara Y; Shinomiya N; Seki S; Nemoto K; Hamblin MR; Morimoto Y
    Lasers Surg Med; 2011 Mar; 43(3):221-9. PubMed ID: 21412806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macroscopic singlet oxygen modeling for dosimetry of Photofrin-mediated photodynamic therapy: an in-vivo study.
    Qiu H; Kim MM; Penjweini R; Zhu TC
    J Biomed Opt; 2016 Aug; 21(8):88002. PubMed ID: 27552311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers.
    Lilge L; Wilson BC
    J Clin Laser Med Surg; 1998 Apr; 16(2):81-91. PubMed ID: 9663099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photofrin photodynamic therapy: 2.0 mg/kg or not 2.0 mg/kg that is the question.
    Allison RR; Sibata CH
    Photodiagnosis Photodyn Ther; 2008 Jun; 5(2):112-9. PubMed ID: 19356641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of drug-light interval on the mode of action of Photofrin photodynamic therapy in a mouse tumor model.
    Li LB; Luo RC
    Lasers Med Sci; 2009 Jul; 24(4):597-603. PubMed ID: 18936869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperoxygenation enhances the tumor cell killing of photofrin-mediated photodynamic therapy.
    Huang Z; Chen Q; Shakil A; Chen H; Beckers J; Shapiro H; Hetzel FW
    Photochem Photobiol; 2003 Nov; 78(5):496-502. PubMed ID: 14653582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen.
    Busch TM; Wileyto EP; Emanuele MJ; Del Piero F; Marconato L; Glatstein E; Koch CJ
    Cancer Res; 2002 Dec; 62(24):7273-9. PubMed ID: 12499269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial Doppler optical coherence tomography monitors microvascular changes during photodynamic therapy in a Dunning prostate model under varying treatment conditions.
    Standish BA; Jin X; Smolen J; Mariampillai A; Munce NR; Wilson BC; Vitkin IA; Yang VX
    J Biomed Opt; 2007; 12(3):034022. PubMed ID: 17614730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effect of photodynamic therapy in mice using direct application of Photofrin dissolved in lidocaine jelly.
    Murakami H; Kohno E; Kohmura Y; Ozawa H; Ito H; Sugihara K; Horiuchi K; Hirano T; Kanayama N
    Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):259-63. PubMed ID: 19747245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy.
    Lilge L; Olivo MC; Schatz SW; MaGuire JA; Patterson MS; Wilson BC
    Br J Cancer; 1996 Feb; 73(3):332-43. PubMed ID: 8562339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.